Atossa Therapeutics:H.C. Wainwright将目标价调整至25美元,以反映1:15的反向股票分割

美股速递
Mar 26

H.C. Wainwright已将Atossa Therapeutics的目标股价调整为25美元,这一调整旨在反映该公司近期实施的1:15反向股票分割。反向股票分割后,公司流通股数量减少,每股价格相应提升,而目标价的调整则体现了这一股权结构变化对估值的影响。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10